| Name | Title | Contact Details |
|---|
Assessment Technologies Institute is a Stilwell, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use.
Sunyard is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Since 1997, Network Health has been committed of improving the health and well-being of its members and their diverse communities. Today the company provides high-quality, comprehensive health care coverage to more than 160,000 residents who qualify for Mass Health and Commonwealth Care in more than 300 cities and towns across Massachusetts.